| Jul 18 |
Champions Oncology, Inc. (CSBR) Q4 2024 Earnings Call Transcript
|
| Jul 18 |
Champions Oncology Non-GAAP EPS of $0.01, revenue of $14M beats by $1.31M
|
| Jul 18 |
Champions Oncology Reports Quarterly Revenue of $14.0 Million
|
| Jul 11 |
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 18, 2024
|
| Jun 4 |
Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development
|
| May 21 |
Champions Oncology (NASDAQ:CSBR) shareholders have endured a 53% loss from investing in the stock three years ago
|
